1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Global Joint Pain Injections Market- Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence
5 Global Joint Pain Injections Market Landscape
5.1 Historical and Current Market Trends (2018-2023)
5.2 Market Forecast (2024-2032)
6 Global Joint Pain Injections Market - Breakup by Type of Injection
6.1 Steroid Joint Injections
6.1.1 Overview
6.1.2 Historical and Current Market Trends (2018-2023)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2024-2032)
6.2 Hyaluronic Acid Injections
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2018-2023)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2024-2032)
6.3 Platelet-rich Plasma (PRP) Injections
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2018-2023)
6.3.3 Market Segmentation
6.3.4 Market Forecast (2024-2032)
6.4 Placental Tissue Matrix (PTM) Injections
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2018-2023)
6.4.3 Market Segmentation
6.4.4 Market Forecast (2024-2032)
6.5 Others
6.5.1 Historical and Current Market Trends (2018-2023)
6.5.2 Market Forecast (2024-2032)
6.6 Attractive Investment Proposition by Type of Injection
7 Global Joint Pain Injections Market- Breakup by Joint Type
7.1 Knee and Ankle
7.1.1 Overview
7.1.2 Historical and Current Market Trends (2018-2023)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2024-2032)
7.2 Hip Joint
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2018-2023)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2024-2032)
7.3 Shoulder and Elbow
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2018-2023)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2024-2032)
7.4 Facet Joints of the Spine
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2018-2023)
7.4.3 Market Segmentation
7.4.4 Market Forecast (2024-2032)
7.5 Others
7.5.1 Historical and Current Market Trends (2018-2023)
7.5.2 Market Forecast (2024-2032)
7.6 Attractive Investment Proposition by Joint Type
8 Global Joint Pain Injections Market- Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Overview
8.1.2 Historical and Current Market Trends (2018-2023)
8.1.3 Market Segmentation
8.1.3.1 Public Hospital Pharmacies
8.1.3.2 Private Hospital Pharmacies
8.1.4 Market Forecast (2024-2032)
8.2 Drug Stores and Retail Pharmacies
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2018-2023)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2024-2032)
8.3 Online Providers
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2018-2023)
8.3.3 Market Segmentation
8.3.4 Market Forecast (2024-2032)
8.4 Attractive Investment Proposition by Distribution Channel
9 Global Joint Pain Injections Market– Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Drivers
9.1.1.2 Historical and Current Market Trends (2018-2023)
9.1.1.3 Market Breakup by Type of Injection
9.1.1.4 Market Breakup by Joint Type
9.1.1.5 Market Breakup by Distribution Channel
9.1.1.6 Key Players
9.1.1.7 Market Forecast (2024-2032)
9.1.2 Canada
9.1.2.1 Market Drivers
9.1.2.2 Historical and Current Market Trends (2018-2023)
9.1.2.3 Market Breakup by Type of Injection
9.1.2.4 Market Breakup by Joint Type
9.1.2.5 Market Breakup by Distribution Channel
9.1.2.6 Key Players
9.1.2.7 Market Forecast (2024-2032)
9.2 Europe
9.2.1 Germany
9.2.1.1 Market Drivers
9.2.1.2 Historical and Current Market Trends (2018-2023)
9.2.1.3 Market Breakup by Type of Injection
9.2.1.4 Market Breakup by Joint Type
9.2.1.5 Market Breakup by Distribution Channel
9.2.1.6 Key Players
9.2.1.7 Market Forecast (2024-2032)
9.2.2 France
9.2.2.1 Market Drivers
9.2.2.2 Historical and Current Market Trends (2018-2023)
9.2.2.3 Market Breakup by Type of Injection
9.2.2.4 Market Breakup by Joint Type
9.2.2.5 Market Breakup by Distribution Channel
9.2.2.6 Key Players
9.2.2.7 Market Forecast (2024-2032)
9.2.3 United Kingdom
9.2.3.1 Market Drivers
9.2.3.2 Historical and Current Market Trends (2018-2023)
9.2.3.3 Market Breakup by Type of Injection
9.2.3.4 Market Breakup by Joint Type
9.2.3.5 Market Breakup by Distribution Channel
9.2.3.6 Key Players
9.2.3.7 Market Forecast (2024-2032)
9.2.4 Italy
9.2.4.1 Market Drivers
9.2.4.2 Historical and Current Market Trends (2018-2023)
9.2.4.3 Market Breakup by Type of Injection
9.2.4.4 Market Breakup by Joint Type
9.2.4.5 Market Breakup by Distribution Channel
9.2.4.6 Key Players
9.2.4.7 Market Forecast (2024-2032)
9.2.5 Spain
9.2.5.1 Market Drivers
9.2.5.2 Historical and Current Market Trends (2018-2023)
9.2.5.3 Market Breakup by Type of Injection
9.2.5.4 Market Breakup by Joint Type
9.2.5.5 Market Breakup by Distribution Channel
9.2.5.6 Key Players
9.2.5.7 Market Forecast (2024-2032)
9.2.6 Others
9.2.6.1 Historical and Current Market Trends (2018-2023)
9.2.6.2 Market Forecast (2024-2032)
9.3 Asia Pacific
9.3.1 China
9.3.1.1 Market Drivers
9.3.1.2 Historical and Current Market Trends (2018-2023)
9.3.1.3 Market Breakup by Type of Injection
9.3.1.4 Market Breakup by Joint Type
9.3.1.5 Market Breakup by Distribution Channel
9.3.1.6 Key Players
9.3.1.7 Market Forecast (2024-2032)
9.3.2 Japan
9.3.2.1 Market Drivers
9.3.2.2 Historical and Current Market Trends (2018-2023)
9.3.2.3 Market Breakup by Type of Injection
9.3.2.4 Market Breakup by Joint Type
9.3.2.5 Market Breakup by Distribution Channel
9.3.2.6 Key Players
9.3.2.7 Market Forecast (2024-2032)
9.3.3 India
9.3.3.1 Market Drivers
9.3.3.2 Historical and Current Market Trends (2018-2023)
9.3.3.3 Market Breakup by Type of Injection
9.3.3.4 Market Breakup by Joint Type
9.3.3.5 Market Breakup by Distribution Channel
9.3.3.6 Key Players
9.3.3.7 Market Forecast (2024-2032)
9.3.4 South Korea
9.3.4.1 Market Drivers
9.3.4.2 Historical and Current Market Trends (2018-2023)
9.3.4.3 Market Breakup by Type of Injection
9.3.4.4 Market Breakup by Joint Type
9.3.4.5 Market Breakup by Distribution Channel
9.3.4.6 Key Players
9.3.4.7 Market Forecast (2024-2032)
9.3.5 Australia
9.3.5.1 Market Drivers
9.3.5.2 Historical and Current Market Trends (2018-2023)
9.3.5.3 Market Breakup by Type of Injection
9.3.5.4 Market Breakup by Joint Type
9.3.5.5 Market Breakup by Distribution Channel
9.3.5.6 Key Players
9.3.5.7 Market Forecast (2024-2032)
9.3.6 Indonesia
9.3.6.1 Market Drivers
9.3.6.2 Historical and Current Market Trends (2018-2023)
9.3.6.3 Market Breakup by Type of Injection
9.3.6.4 Market Breakup by Joint Type
9.3.6.5 Market Breakup by Distribution Channel
9.3.6.6 Key Players
9.3.6.7 Market Forecast (2024-2032)
9.3.7 Others
9.3.7.1 Historical and Current Market Trends (2018-2023)
9.3.7.2 Market Forecast (2024-2032)
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Drivers
9.4.1.2 Historical and Current Market Trends (2018-2023)
9.4.1.3 Market Breakup by Type of Injection
9.4.1.4 Market Breakup by Joint Type
9.4.1.5 Market Breakup by Distribution Channel
9.4.1.6 Key Players
9.4.1.7 Market Forecast (2024-2032)
9.4.2 Mexico
9.4.2.1 Market Drivers
9.4.2.2 Historical and Current Market Trends (2018-2023)
9.4.2.3 Market Breakup by Type of Injection
9.4.2.4 Market Breakup by Joint Type
9.4.2.5 Market Breakup by Distribution Channel
9.4.2.6 Key Players
9.4.2.7 Market Forecast (2024-2032)
9.4.3 Others
9.4.3.1 Historical and Current Market Trends (2018-2023)
9.4.3.2 Market Forecast (2024-2032)
9.5 Middle East and Africa
9.5.1 Market Drivers
9.5.2 Historical and Current Market Trends (2018-2023)
9.5.3 Market Breakup by Type of Injection
9.5.4 Market Breakup by Joint Type
9.5.5 Market Breakup by Distribution Channel
9.5.6 Market Breakup by Country
9.5.7 Key Players
9.5.8 Market Forecast (2024-2032)
9.6 Attractive Investment Proposition by Region
10 Global Joint Pain Injections Market– Competitive Landscape
10.1 Overview
10.2 Market Structure
10.3 Market Share by Key Players
10.4 Market Player Positioning
10.5 Top Winning Strategies
10.6 Competitive Dashboard
10.7 Company Evaluation Quadrant
11 Profiles of Key Players
11.1 Anika Therapeutics Inc.
11.1.1 Business Overview
11.1.2 Product Portfolio
11.1.3 Business Strategies
11.1.4 Financials
11.1.5 SWOT Analysis
11.1.6 Major News and Events
11.2 Bioventus LLC
11.2.1 Business Overview
11.2.2 Product Portfolio
11.2.3 Business Strategies
11.2.4 Financials
11.2.5 SWOT Analysis
11.2.6 Major News and Events
11.3 OrthogenRx Inc. (Avanos Medical Inc.)
11.3.1 Business Overview
11.3.2 Product Portfolio
11.3.3 Business Strategies
11.3.4 SWOT Analysis
11.3.5 Major News and Events
11.4 Sanofi
11.4.1 Business Overview
11.4.2 Product Portfolio
11.4.3 Business Strategies
11.4.4 Financials
11.4.5 SWOT Analysis
11.4.6 Major News and Events
11.5 Zimmer Biomet Inc.
11.5.1 Business Overview
11.5.2 Product Portfolio
11.5.3 Business Strategies
11.5.4 Financials
11.5.5 SWOT Analysis
11.5.6 Major News and Events
Please note that this is only a partial list of the key players, and the complete list is provided in the report.
12 Global Joint Pain Injections Market- Industry Analysis
12.1 Drivers, Restraints, and Opportunities
12.1.1 Overview
12.1.2 Drivers
12.1.3 Restraints
12.1.4 Opportunities
12.1.5 Impact Analysis
12.2 Porters Five Forces Analysis
12.2.1 Overview
12.2.2 Bargaining Power of Buyers
12.2.3 Bargaining Power of Suppliers
12.2.4 Degree of Competition
12.2.5 Threat of New Entrants
12.2.6 Threat of Substitutes
12.3 Value Chain Analysis
13 Strategic Recommendations
14 Appendix